Medulloblastoma
Showing NaN - NaN of 12
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive
Recruiting
- Medulloblastoma
- Central Nervous System Embryonal Tumors
- Induction
- +2 more
-
Birmingham, Alabama
- +61 more
Feb 16, 2022
Anaplastic Medulloblastoma, Medulloblastoma Trial in Worldwide (drug, biological, other, radiation)
Active, not recruiting
- Anaplastic Medulloblastoma
- Medulloblastoma
- Carboplatin
- +8 more
-
Birmingham, Alabama
- +195 more
Jan 4, 2022
Brain Tumor, Medulloblastoma, Pineoblastoma Trial in Boston, Houston (proton beam radiation)
Active, not recruiting
- Brain Tumor
- +2 more
- proton beam radiation
-
Boston, Massachusetts
- +1 more
Sep 30, 2021